GEOGRAPHIC ATROPHY
Clinical trials for GEOGRAPHIC ATROPHY explained in plain language.
Never miss a new study
Get alerted when new GEOGRAPHIC ATROPHY trials appear
Sign up with your email to follow new studies for GEOGRAPHIC ATROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene therapy for dry AMD shows promise but trial halted early
Disease control TerminatedThis early-phase study tested a single injection of GT005 gene therapy in 56 people with dry age-related macular degeneration (AMD), a leading cause of vision loss. The goal was to check safety and how well the treatment worked. The trial was stopped early, but results help guide…
Matched conditions: GEOGRAPHIC ATROPHY
Phase: PHASE1, PHASE2 • Sponsor: Gyroscope Therapeutics Limited • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Eye disease drug trial halted: danicopan fails to slow vision loss?
Disease control TerminatedThis study tested a drug called danicopan in 365 people with geographic atrophy, a form of advanced age-related macular degeneration that causes blind spots. The goal was to see if different doses could slow the growth of these spots over two years. The trial was stopped early, s…
Matched conditions: GEOGRAPHIC ATROPHY
Phase: PHASE2 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 04, 2026 16:23 UTC